Ellen Wang

Ellen Wang currently serves as the Head of China CMC Regulatory Affairs at 勃林格殷格翰 since June 2022, overseeing CMC regulatory affairs in China. Prior to this role, Ellen was the Senior Director of Regulatory Affairs at CStone Pharmaceuticals, managing regulatory activities for oncology products from June 2021 to June 2022. Ellen has held multiple positions at 勃林格殷格翰 from May 2015 to June 2021, including Associate Director of Regulatory Affairs and Senior Manager of Regulatory Affairs with a focus on cardiovascular and metabolism products. Ellen's earlier experience includes serving as Assistant Manager of Regulatory Affairs at Johnson & Johnson and as RA Manager at SUN PHARMA. Ellen holds a Master's degree in Pharmaceutical Analysis and a Bachelor's degree in Pharmaceutical Engineering from Beijing University of Chinese Medicine.